October 2014 - FRMC

Department

Conference Insider

Managing Chronic Kidney Disease in Older Adults

11/03/2014

Eileen Koutnik-Fotopoulos

Chronic kidney disease is pervasive in the older population. The progression of CKD can have a significant affect on the overall prognosis of a geriatric patient.

Chronic kidney disease is...

11/03/2014

First Report Managed Care

Conference Insider

Preventing the Spread of Infection in Long-Term Care Facilities

11/03/2014

Melissa D. Cooper

Anaheim—In 2014, the Centers for Disease Control and Prevention (CDC) reported that >200 Americans die each day from a hospital-acquired infection. As such, healthcare professionals should be vigilant to reduce the risk of infection in...

Anaheim—In 2014, the Centers...

11/03/2014

First Report Managed Care

Conference Insider

Balancing Optimal End-of-Life Care with Resident Wishes

11/03/2014

Melissa D. Cooper

Anaheim—The goal of end-of-life care is to provide patients with the highest quality of care and the highest quality of life possible.

Anaheim—The goal of...

11/03/2014

First Report Managed Care

Conference Insider

Implementing a QAPI Program in Nursing Homes

11/03/2014

Eileen Koutnik-Fotopoulos

The Patient Protection and Affordable Care Act requires nursing homes to have an acceptable Quality Assurance and Performance Improvement plan.

The Patient Protection and...

11/03/2014

First Report Managed Care

Prescribing Considerations for Antithrombotic Prophylaxis

11/03/2014

Eileen Koutnik-Fotopoulos

Disorders that require antithrombotic and antiplatelet therapies are prevalent in long-term care (LTC).

Disorders that require...

11/03/2014

First Report Managed Care

Costs Associated with Lung Cancer Screening for Medicare Patients

11/03/2014

Tim Casey

A forecasting model found that after 5 years, low-dose computed tomography lung cancer screening would result in 55,000 more lung cancer diagnoses, 11 million more scans, and $9.3 billion more in direct medical expenditures.

A forecasting model found that...

11/03/2014

First Report Managed Care

Lenvatinib Improves Progression-Free Survival in Patients with Thyroid Cancer

11/03/2014

Tim Casey

Patients with radioiodine-resistant, advanced differentiated thyroid cancer who received lenvatinib had a significantly greater progression-free survival compared with patients who received placebo, according to new research.

Patients with...

11/03/2014

First Report Managed Care

Ibrutinib Superior to Ofatumumab for Previously Treated CLL or SLL

11/03/2014

Tim Casey

Chicago—At a median follow-up of 9.4 months, patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib had a significant increase in overall survival and progression-free...

Chicago—At a median follow-up of...

11/03/2014

First Report Managed Care

Exemestane versus Tamoxifen for Women with Premenopausal Breast Cancer

11/03/2014

Tim Casey

After a median follow-up of 5.7 years, an analysis found that premenopausal women with HR+ early breast cancer who received exemestane plus ovarian function suppression had a significant improvement in disease-free survival.

After a median follow-up of 5.7...

11/03/2014

First Report Managed Care

Bortezomib-Based Therapy as Frontline Treatment for Newly Diagnosed MCL

11/03/2014

Tim Casey

Chicago—Patients with newly diagnosed mantle cell lymphoma (MCL) who received a bortezomib-based combination therapy had a significant increase in progression-free survival compared with a group who received standard frontline therapy.

Chicago—Patients with newly...

11/03/2014

First Report Managed Care

Behind the Bill

SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power

04/02/2025

Katie Hayes, MJ

The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...

The Supreme Court recently heard...

04/02/2025

First Report Managed Care

Behind the Bill

Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”

03/26/2025

Katie Hayes, MJ

On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...

On Tuesday, March 25, 2025, the...

03/26/2025

First Report Managed Care

Behind the Bill

The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid

03/19/2025

Katie Hayes, MJ

Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...

Last week, I explored the $880...

03/19/2025

First Report Managed Care

Behind the Bill

The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?

03/12/2025

Katie Hayes, MJ

I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...

I’d like to step away from...

03/12/2025

First Report Managed Care

Behind the Bill

RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking

03/05/2025

Katie Hayes, MJ

The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...

The erosion of administrative...

03/05/2025

First Report Managed Care

Behind the Bill

Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction

02/26/2025

Katie Hayes, MJ

The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...

The dust has barely settled from...

02/26/2025

First Report Managed Care

Behind the Bill

The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)

02/19/2025

Katie Hayes, MJ

Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...

Last week, I explored the...

02/19/2025

First Report Managed Care

Behind the Bill

The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)

02/12/2025

Katie Hayes, MJ

Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...

Just when you thought the dust...

02/12/2025

First Report Managed Care

Behind the Bill

No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries

02/05/2025

Katie Hayes, MJ

On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...

On inauguration day, President...

02/05/2025

First Report Managed Care

Behind the Bill

Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate

01/29/2025

Katie Hayes, MJ

The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...

The Plot Thickens in Drug...

01/29/2025

First Report Managed Care